Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Phosphoproteome and drug response effects mediated by the three Protein Phosphatase 2A inhibitor proteins CIP2A, SET and PME-1.

Kauko O, Imanishi SY, Kulesskiy E, Yetukuri L, Laajala TD, Sharma M, Pavic K, Aakula A, Rupp C, Jumppanen M, Haapaniemi P, Ruan L, Yadav B, Suni V, Varila T, Corthals GL, Reimand J, Wennerberg K, Aittokallio T, Westermarck J.

J Biol Chem. 2020 Feb 18. pii: jbc.RA119.011265. doi: 10.1074/jbc.RA119.011265. [Epub ahead of print]

2.

Characterization of lignin enforced tannin/furanic foams.

Varila T, Romar H, Luukkonen T, Hilli T, Lassi U.

Heliyon. 2020 Jan 28;6(1):e03228. doi: 10.1016/j.heliyon.2020.e03228. eCollection 2020 Jan.

3.

Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.

Mäkelä E, Löyttyniemi E, Salmenniemi U, Kauko O, Varila T, Kairisto V, Itälä-Remes M, Westermarck J.

Cancers (Basel). 2019 Nov 11;11(11). pii: E1774. doi: 10.3390/cancers11111774.

4.

PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.

Kauko O, O'Connor CM, Kulesskiy E, Sangodkar J, Aakula A, Izadmehr S, Yetukuri L, Yadav B, Padzik A, Laajala TD, Haapaniemi P, Momeny M, Varila T, Ohlmeyer M, Aittokallio T, Wennerberg K, Narla G, Westermarck J.

Sci Transl Med. 2018 Jul 18;10(450). pii: eaaq1093. doi: 10.1126/scitranslmed.aaq1093.

PMID:
30021885

Supplemental Content

Loading ...
Support Center